Association to the Glypican-5 gene in multiple sclerosis

Journal of Neuroimmunology

Volumn 226, Issue 1-2, 2010, Pages 194-197

  Lorentzen, Aslaug R ^a,b   Melum, Espen ^b   Ellinghaus, Eva ^c   Smestad, Cathrine ^d   Mero, Inger Lise ^b,d   Aarseth, Jan H ^e   Myhr, Kjell Morten ^e,f   Celius, Elisabeth G ^d   Lie, Benedicte A ^b   Karlsen, Tom H ^b   Franke, Andre ^c   Harbo, Hanne F ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF KIEL   (Germany)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF BERGEN   (Norway)

Author keywords

Genetics; Glypican 5; Glypican 6; Immune mediated disease; Multiple sclerosis

Indexed keywords

GLYPICAN; GLYPICAN 5; GLYPICAN 6; HLA ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 13Q; CONTROLLED STUDY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; INTRON; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NORWAY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ADULT; AGED; CASE CONTROL STUDY; CHILD; CHROMOSOME 13; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHROMOSOMES, HUMAN, PAIR 13; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GLYPICANS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NORWAY; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 77956395532     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.07.003     Document Type: Article

References (24)

1. Arking D.E., Reinier K., Post W., Jui J., Hilton G., O'Connor A., Prineas R.J., Boerwinkle E., Psaty B.M., Tomaselli G.F., Rea T., Sotoodehnia N., Siscovick D.S., Burke G.L., Marban E., Spooner P.M., Chakravarti A., Chugh S.S. Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest. PLoS One 2010, 5(3):e9879.
2. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet. 2009, 41(7):824-828.
3. Baranzini S.E., Wang J., Gibson R.A., Galwey N., Naegelin Y., Barkhof F., Radue E.W., Lindberg R.L., Uitdehaag B.M., Johnson M.R., Angelakopoulou A., Hall L., Richardson J.C., Prinjha R.K., Gass A., Geurts J.J., Kragt J., Sombekke M., Vrenken H., Qualley P., Lincoln R.R., Gomez R., Caillier S.J., George M.F., Mousavi H., Guerrero R., Okuda D.T., Cree B.A., Green A.J., Waubant E., Goodin D.S., Pelletier D., Matthews P.M., Hauser S.L., Kappos L., Polman C.H., Oksenberg J.R. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum. Mol. Genet. 2009, 18(4):767-778.
4. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
5. Byun E., Caillier S.J., Montalban X., Villoslada P., Fernandez O., Brassat D., Comabella M., Wang J., Barcellos L.F., Baranzini S.E., Oksenberg J.R. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis. Arch. Neurol. 2008, 65(3):337-344.
6. Celie J.W., Beelen R.H., van den Born J. Heparan sulfate proteoglycans in extravasation: assisting leukocyte guidance. Front. Biosci. 2009, 14:4932-4949.
7. Cenit M.D., Blanco-Kelly F., del.H.V., Bartolome M., de la Concha E.G., Urcelay E., Arroyo R., Martinez A. Glypican 5 is an interferon-beta response gene: a replication study. Mult. Scler. 2009, 15(8):913-917.
8. Comabella M., Craig D.W., Camina-Tato M., Morcillo C., Lopez C., Navarro A., Rio J., Montalban X., Martin R. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS One 2008, 3(10):e3490.
9. De Jager P.L., Jia X., Wang J., de Bakker P.I., Ottoboni L., Aggarwal N.T., Piccio L., Raychaudhuri S., Tran D., Aubin C., Briskin R., Romano S., Baranzini S.E., McCauley J.L., Pericak-Vance M.A., Haines J.L., Gibson R.A., Naeglin Y., Uitdehaag B., Matthews P.M., Kappos L., Polman C., McArdle W.L., Strachan D.P., Evans D., Cross A.H., Daly M.J., Compston A., Sawcer S.J., Weiner H.L., Hauser S.L., Hafler D.A., Oksenberg J.R. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 2009, 41(7):776-782.
10. Dupont W.D., Plummer W.D. Power and sample size calculations. A review and computer program. Control Clin. Trials 1990, 11(2):116-128.
11. Filmus J., Capurro M., Rast J. Glypicans. Genome Biol. 2008, 9(5):224.
12. International Multiple Sclerosis Genetics Consortium (IMSGC) Refining genetic associations in multiple sclerosis. Lancet Neurol. 2008, 7(7):567-569.
13. International Multiple Sclerosis Genetics Consortium, Hafler, D.A., Compston, A., Sawcer, S., Lander, E.S., Daly, M.J., De Jager, P.L., de Bakker, P.I., Gabriel, S.B., Mirel, D.B., Ivinson, A.J., Pericak-Vance, M.A., Gregory, S.G., Rioux, J.D., McCauley, J.L., Haines, J.L., Barcellos, L.F., Cree, B., Oksenberg, J.R., Hauser, S.L. 2007. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med., 357, (9) 851-862.
14. Jallow M., Teo Y.Y., Small K.S., Rockett K.A., Deloukas P., Clark T.G., Kivinen K., Bojang K.A., Conway D.J., Pinder M., Sirugo G., Sisay-Joof F., Usen S., Auburn S., Bumpstead S.J., Campino S., Coffey A., Dunham A., Fry A.E., Green A., Gwilliam R., Hunt S.E., Inouye M., Jeffreys A.E., Mendy A., Palotie A., Potter S., Ragoussis J., Rogers J., Rowlands K., Somaskantharajah E., Whittaker P., Widden C., Donnelly P., Howie B., Marchini J., Morris A., Sanjoaquin M., Achidi E.A., Agbenyega T., Allen A., Amodu O., Corran P., Djimde A., Dolo A., Doumbo O.K., Drakeley C., Dunstan S., Evans J., Farrar J., Fernando D., Hien T.T., Horstmann R.D., Ibrahim M., Karunaweera N., Kokwaro G., Koram K.A., Lemnge M., Makani J., Marsh K., Michon P., Modiano D., Molyneux M.E., Mueller I., Parker M., Peshu N., Plowe C.V., Puijalon O., Reeder J., Reyburn H., Riley E.M., Sakuntabhai A., Singhasivanon P., Sirima S., Tall A., Taylor T.E., Thera M., Troye-Blomberg M., Williams T.N., Wilson M., Kwiatkowski D.P. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat. Genet. 2009, 41:657-665.
15. Jersild C., Svejgaard A., Fog T. HL-A antigens and multiple sclerosis. Lancet 1972, 1(7762):1240-1241.
16. Johnson B.A., Wang J., Taylor E.M., Caillier S.J., Herbert J., Khan O.A., Cross A.H., De Jager P.L., Gourraud P.A., Cree B.C., Hauser S.L., Oksenberg J.R. Multiple sclerosis susceptibility alleles in African Americans. Genes Immun. 2010, 11(4):343-350.
17. Karlsen T.H., Franke A., Melum E., Kaser A., Hov J.R., Balschun T., Lie B.A., Bergquist A., Schramm C., Weismuller T.J., Gotthardt D., Rust C., Philipp E.E., Fritz T., Henckaerts L., Weersma R.K., Stokkers P., Ponsioen C.Y., Wijmenga C., Sterneck M., Nothnagel M., Hampe J., Teufel A., Runz H., Rosenstiel P., Stiehl A., Vermeire S., Beuers U., Manns M.P., Schrumpf E., Boberg K.M., Schreiber S. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 2010, 138(3):1102-1111.
18. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001, 50(1):121-127.
19. Oksenberg J.R., Baranzini S.E., Sawcer S., Hauser S.L. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat. Rev. Genet. 2008, 9(7):516-526.
20. Olerup O., Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991, 38(1):1-15.
21. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983, 13(3):227-231.
22. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81(3):559-575.
23. Weersma R.K., Stokkers P.C., Cleynen I., Wolfkamp S.C., Henckaerts L., Schreiber S., Dijkstra G., Franke A., Nolte I.M., Rutgeerts P., Wijmenga C., Vermeire S. Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort. Am. J. Gastroenterol. 2009, 104(3):630-638.
24. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(7145):661-678.